Next, to assess the phenotypic characterization of DC/tumor, the mean fluorescence intensity (MFI) of HLA-DR and CD86 expression by DC/tumor were determined by FACS analysis, where the fused cells were identified as MUC1+HLA-DR+ or MUC1+CD86+. Here, CD86 is linked to neoplasm.